First Time Loading...

Phreesia Inc
NYSE:PHR

Watchlist Manager
Phreesia Inc Logo
Phreesia Inc
NYSE:PHR
Watchlist
Price: 23.93 USD -1.89% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. [ Read More ]

The intrinsic value of one PHR stock under the Base Case scenario is 17.47 USD. Compared to the current market price of 23.93 USD, Phreesia Inc is Overvalued by 27%.

Key Points:
PHR Intrinsic Value
Base Case
17.47 USD
Overvaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Phreesia Inc

Backtest PHR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PHR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Phreesia Q4 Earnings: Growth and Profitability Focus
2024-Q4 Earnings Call

Phreesia Q4 Earnings: Growth and Profitability Focus

Phreesia wrapped up fiscal 2024 with a bang, seeing patient visits soar 25% to over 150 million and revenue jump 24% to $95 million. Despite an adjusted EBITDA still in the red at negative $3.5 million, it's a solid $14 million year-over-year improvement. Looking ahead, they're sticking to their fiscal 2025 forecast with revenues expected between $424 to $434 million and a spruced up adjusted EBITDA outlook now ranging from $12 million to $20 million. Driven by operational efficiencies, they anticipate at least 100 new average health care services clients in their first quarter, all while confidently planning for a profitable fiscal 2026, backed by a robust cash balance.

Financials

Balance Sheet Decomposition
Phreesia Inc

Current Assets 195.7m
Cash & Short-Term Investments 87.5m
Receivables 92.9m
Other Current Assets 15.2m
Non-Current Assets 174.6m
PP&E 17.2m
Intangibles 153.6m
Other Non-Current Assets 3.9m
Current Liabilities 110.1m
Accounts Payable 8.5m
Accrued Liabilities 37.5m
Other Current Liabilities 64.1m
Non-Current Liabilities 8.8m
Long-Term Debt 5.4m
Other Non-Current Liabilities 3.4m
Efficiency

Earnings Waterfall
Phreesia Inc

Revenue
356.3m USD
Cost of Revenue
-124m USD
Gross Profit
232.3m USD
Operating Expenses
-368.8m USD
Operating Income
-136.5m USD
Other Expenses
-406k USD
Net Income
-136.9m USD

Free Cash Flow Analysis
Phreesia Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

PHR Profitability Score
Profitability Due Diligence

Phreesia Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Declining ROE
23/100
Profitability
Score

Phreesia Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

PHR Solvency Score
Solvency Due Diligence

Phreesia Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
65/100
Solvency
Score

Phreesia Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHR Price Targets Summary
Phreesia Inc

Wall Street analysts forecast PHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHR is 28.94 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.

Lowest
Price Target
17.17 USD
28% Downside
Average
Price Target
28.94 USD
21% Upside
Highest
Price Target
37.8 USD
58% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PHR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PHR Price
Phreesia Inc

1M 1M
-3%
6M 6M
+28%
1Y 1Y
-22%
3Y 3Y
-53%
5Y 5Y
-5%
10Y 10Y
-5%
Annual Price Range
23.93
52w Low
12.39
52w High
34.52
Price Metrics
Average Annual Return 14.67%
Standard Deviation of Annual Returns 58.94%
Max Drawdown -85%
Shares Statistics
Market Capitalization 1.3B USD
Shares Outstanding 56 354 600
Percentage of Shares Shorted 4.53%

PHR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Phreesia Inc Logo
Phreesia Inc

Country

United States of America

Industry

Health Care

Market Cap

1.3B USD

Dividend Yield

0%

Description

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Raleigh, North Carolina and currently employs 1,701 full-time employees. The company went IPO on 2019-07-18. The firm offers software-as-a-service (SaaS) based technology platform, namely Phreesia Platform, which offers healthcare services clients with a suite of integrated solutions that manage patient access, registration, payments and clinical support. Its platform operates as a single, unified, multi-tenant platform that has demonstrated scalability and seamless integration within the operating infrastructure of its healthcare services clients. The Company’s platform offers various solutions to its clients, which includes appointments, registration, revenue cycle, clinical support, COVID-19 product offerings, patient activation and life sciences solutions. The company serves an array of provider clients ranging from single-specialty practices, which include internal and family medicine, urology, dermatology, and orthopedics to multi-specialty groups and health systems, as well as regional and national payers and other organizations.

Contact

NORTH CAROLINA
Raleigh
434 Fayetteville St., Suite 1400
+16467479959.0
https://www.phreesia.com

IPO

2019-07-18

Employees

1 701

Officers

Co-Founder, CEO & Director
Mr. Chaim Indig
Co-Founder & COO
Mr. Evan Roberts
Senior Vice President of Life Sciences
Mr. David Linetsky
Chief Financial Officer
Mr. Balaji Gandhi
VP, Principal Accounting Officer & Controller
Ms. Janet M. Gunzburg
Chief Technology Officer
Mr. Jack Callahan
Show More
General Counsel & Secretary
Ms. Allison C. Hoffman
Vice President of Corporate Communications
Ms. Maureen McKinney
Vice President of Marketing
Ms. Kharen Hauck
Senior Vice President of Human Resources
Ms. Amy Beth VanDuyn
Show Less

See Also

Discover More
What is the Intrinsic Value of one PHR stock?

The intrinsic value of one PHR stock under the Base Case scenario is 17.47 USD.

Is PHR stock undervalued or overvalued?

Compared to the current market price of 23.93 USD, Phreesia Inc is Overvalued by 27%.